Business Description
Trident Texofab Ltd
ISIN : INE071Y01013
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.21 | |||||
Debt-to-Equity | 2.29 | |||||
Debt-to-EBITDA | 4.11 | |||||
Interest Coverage | 0.81 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.64 | |||||
Beneish M-Score | -2.46 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 25.5 | |||||
3-Year EBITDA Growth Rate | 21.6 | |||||
3-Year EPS without NRI Growth Rate | 35.1 | |||||
3-Year Book Growth Rate | 10.7 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 86.57 | |||||
9-Day RSI | 77.98 | |||||
14-Day RSI | 76.47 | |||||
6-1 Month Momentum % | 129.44 | |||||
12-1 Month Momentum % | 67.09 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.33 | |||||
Quick Ratio | 1.08 | |||||
Days Inventory | 47 | |||||
Days Sales Outstanding | 141.63 | |||||
Days Payable | 72.47 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -1.39 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 12.7 | |||||
Operating Margin % | 4.56 | |||||
Net Margin % | 2.05 | |||||
FCF Margin % | 2.52 | |||||
ROE % | 12.93 | |||||
ROA % | 2.56 | |||||
ROIC % | 6.71 | |||||
ROC (Joel Greenblatt) % | 15.93 | |||||
ROCE % | 20.74 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 54.13 | |||||
PE Ratio without NRI | 61.29 | |||||
Shiller PE Ratio | 104.27 | |||||
PEG Ratio | 2.55 | |||||
PS Ratio | 1.11 | |||||
PB Ratio | 6.49 | |||||
Price-to-Tangible-Book | 6.5 | |||||
Price-to-Free-Cash-Flow | 43.92 | |||||
Price-to-Operating-Cash-Flow | 43 | |||||
EV-to-EBIT | 18.91 | |||||
EV-to-EBITDA | 15.79 | |||||
EV-to-Revenue | 1.49 | |||||
EV-to-FCF | 53.74 | |||||
Price-to-DCF (Earnings Based) | 2.36 | |||||
Price-to-DCF (FCF Based) | 4.41 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.45 | |||||
Price-to-Graham-Number | 4.21 | |||||
Earnings Yield (Greenblatt) % | 5.27 | |||||
FCF Yield % | 2.27 | |||||
Forward Rate of Return (Yacktman) % | 17.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Trident Texofab Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 1,053.413 | ||
EPS (TTM) (₹) | 2.14 | ||
Beta | -3.29 | ||
Volatility % | 132.3 | ||
14-Day RSI | 76.47 | ||
14-Day ATR (₹) | 2.820386 | ||
20-Day SMA (₹) | 107.8965 | ||
12-1 Month Momentum % | 67.09 | ||
52-Week Range (₹) | 36.15 - 121 | ||
Shares Outstanding (Mil) | 10.07 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Trident Texofab Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Trident Texofab Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Trident Texofab Ltd Frequently Asked Questions
What is Trident Texofab Ltd(BOM:540726)'s stock price today?
When is next earnings date of Trident Texofab Ltd(BOM:540726)?
Does Trident Texofab Ltd(BOM:540726) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |